135 related articles for article (PubMed ID: 36263828)
1. Gadoxetic acid (Primovist®) beyond the characterization of hepatic lesions in MRI: the case of biliary leaks.
Salgado-Parente A; Gil-Boronat A; Canales Lachen E; Muñoz Beltrán M
Rev Esp Enferm Dig; 2023 Aug; 115(8):459-460. PubMed ID: 36263828
[TBL] [Abstract][Full Text] [Related]
2. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Role of Gadoxetic Acid in MRI.
Rybczynska D; Pienkowska J; Frydrychowski A; Szurowska E; Jankowska A
Curr Med Imaging; 2020; 16(5):572-577. PubMed ID: 32484091
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study.
Borusewicz P; Stańczyk E; Kubiak K; Spużak J; Glińska-Suchocka K; Jankowski M; Sławuta P; Kubiak-Nowak D; Podgórski P
BMC Vet Res; 2019 Aug; 15(1):293. PubMed ID: 31412920
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.
Hammerstingl R; Huppertz A; Breuer J; Balzer T; Blakeborough A; Carter R; Fusté LC; Heinz-Peer G; Judmaier W; Laniado M; Manfredi RM; Mathieu DG; Müller D; Mortelè K; Reimer P; Reiser MF; Robinson PJ; Shamsi K; Strotzer M; Taupitz M; Tombach B; Valeri G; van Beers BE; Vogl TJ;
Eur Radiol; 2008 Mar; 18(3):457-67. PubMed ID: 18058107
[TBL] [Abstract][Full Text] [Related]
6. Additional value of gadoxetic acid-enhanced MRI to conventional extracellular gadolinium-enhanced MRI for the surgical management of colorectal and neuroendocrine liver metastases.
Morin C; Drolet S; Daigle C; Deshaies I; Ouellet JF; Ball CG; Dixon E; Marceau J; Ouellet JB
HPB (Oxford); 2020 May; 22(5):710-715. PubMed ID: 31640929
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance imaging in liver function analysis. Modern objective reality].
Arutyunyants DE; Khovrin VV; Galyan TN; Kulichkin AS; Tarba NS; Filin AV; Metelin AV
Khirurgiia (Mosk); 2021; (6. Vyp. 2):89-94. PubMed ID: 34032794
[TBL] [Abstract][Full Text] [Related]
8. Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.
Kim YY; Park MS; Aljoqiman KS; Choi JY; Kim MJ
Clin Mol Hepatol; 2019 Sep; 25(3):223-233. PubMed ID: 30661336
[TBL] [Abstract][Full Text] [Related]
9. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
10. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
11. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M
Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid.
Agnello F; Dioguardi Burgio M; Picone D; Vernuccio F; Cabibbo G; Giannitrapani L; Taibbi A; Agrusa A; Bartolotta TV; Galia M; Lagalla R; Midiri M; Brancatelli G
World J Gastroenterol; 2016 Jan; 22(1):103-11. PubMed ID: 26755863
[TBL] [Abstract][Full Text] [Related]
13. Improved management of grade B biliary leaks after complex liver resections using gadoxetic acid disodium-enhanced magnetic resonance cholangiography.
Citterio D; Vaiani M; Sposito C; Rossi RE; Flores M; Battiston C; Mazzaferro V
Surgery; 2021 Aug; 170(2):499-506. PubMed ID: 33745732
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
15. Consensus report from the 9
Koh DM; Ba-Ssalamah A; Brancatelli G; Fananapazir G; Fiel MI; Goshima S; Ju SH; Kartalis N; Kudo M; Lee JM; Murakami T; Seidensticker M; Sirlin CB; Tan CH; Wang J; Yoon JH; Zeng M; Zhou J; Taouli B
Eur Radiol; 2021 Aug; 31(8):5615-5628. PubMed ID: 33523304
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Liver MR Imaging.
Ichikawa S; Goshima S
Magn Reson Med Sci; 2023 Apr; 22(2):157-175. PubMed ID: 36725068
[TBL] [Abstract][Full Text] [Related]
17. Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium.
Rao SX; Wang J; Wang J; Jiang XQ; Long LL; Li ZP; Li ZL; Shen W; Zhao XM; Hu DY; Zhang HM; Zhang L; Huan Y; Liang CH; Song B; Zeng MS
J Dig Dis; 2019 Feb; 20(2):54-61. PubMed ID: 30693659
[No Abstract] [Full Text] [Related]
18. Clinical effect of add-on Primovist-enhanced magnetic resonance imaging on preoperative tumor staging in hepatocellular carcinoma patients.
Jin YJ; Lee JW; Kwon OS; Jung YK; Kwon JH; Jang JW; Kim YS; Kim TH; Jeon YS
J Surg Oncol; 2016 Jul; 114(1):106-11. PubMed ID: 27332047
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of gadoxetic acid-enhanced MRI for the differential diagnosis of focal liver lesions: Comparison between estimated intralesional gadoxetic acid retention by T1 mapping and conventional processing methods.
Morisaka H; Seno D; Sakurai Y; Sano K; Akamine Y; Ichikawa T; Okada Y
Eur J Radiol; 2021 May; 138():109620. PubMed ID: 33713905
[TBL] [Abstract][Full Text] [Related]
20. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
Kim YK; Kim CS; Han YM; Park G
Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
